DOI QR코드

DOI QR Code

Lack of Association between Fingernail Selenium and Thyroid Cancer Risk: A Case-Control Study in French Polynesia

  • Ren, Yan (Radiation Epidemiology Group, Centre for Research in Epidemiology and Population Health (CESP)) ;
  • Kitahara, Cari Meinhold (Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health) ;
  • de Gonzalez, Amy Berrington (Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health) ;
  • Clero, Enora (Radiation Epidemiology Group, Centre for Research in Epidemiology and Population Health (CESP)) ;
  • Brindel, Pauline (Radiation Epidemiology Group, Centre for Research in Epidemiology and Population Health (CESP)) ;
  • Maillard, Stephane (Radiation Epidemiology Group, Centre for Research in Epidemiology and Population Health (CESP)) ;
  • Cote, Suzanne (Area of population health and optimal health practices, CHU de Quebec Research Center) ;
  • Dewailly, Eric (Area of population health and optimal health practices, CHU de Quebec Research Center) ;
  • Rachedi, Frederique (Territorial Hospital Mamao) ;
  • Boissin, Jean-Louis (IPRAME) ;
  • Sebbag, Joseph (Paofai Clinic) ;
  • Shan, Larrys (Endocrinologist) ;
  • Bost-Bezeaud, Frederique (Territorial Hospital Mamao) ;
  • Petitdidier, Patrick (Laboratoire Boz) ;
  • Xhaard, Constance (Radiation Epidemiology Group, Centre for Research in Epidemiology and Population Health (CESP)) ;
  • Rubino, Carole (Radiation Epidemiology Group, Centre for Research in Epidemiology and Population Health (CESP)) ;
  • de Vathaire, Florent (Radiation Epidemiology Group, Centre for Research in Epidemiology and Population Health (CESP))
  • Published : 2014.07.15

Abstract

Background: Numerous studies have suggested that selenium deficiency may be associated with an increased risk for several types of cancer, but few have focused on thyroid cancer. Materials and Methods: We examined the association between post-diagnostic fingernail selenium levels and differentiated thyroid cancer risk in a French Polynesian matched case-control study. Conditional logistic regression models were used to estimate odds ratios and 95% confidence intervals. Results: The median selenium concentration among controls was $0.76{\mu}g/g$. Significantly, we found no association between fingernail selenium levels and thyroid cancer risk after conditioning on year of birth and sex and additionally adjusting for date of birth (highest versus lowest quartile: odds-ratio=1.12, 95% confidence interval: 0.66-1.90; p-trend=0.30). After additional adjustment for other covariates, this association remained non-significant (p-trend=0.60). When restricting the analysis to thyroid cancer of 10 mm or more, selenium in nails was non-significantly positively linked to thyroid cancer risk (p-trend=0.09). Although no significant interaction was evidenced between iodine in nails and selenium in nails effect (p=0.70), a non-significant (p-trend =0.10) positive association between selenium and thyroid cancer risk was seen in patients with less than 3 ppm of iodine in nails. The highest fingernail selenium concentration in French Polynesia was in the Marquises Islands ($M=0.87{\mu}g/g$) and in the Tuamotu-Gambier Archipelago ($M=0.86{\mu}g/g$). Conclusions: Our results do not support, among individuals with sufficient levels of selenium, that greater long-term exposure to selenium may reduce thyroid cancer risk. Because these findings are based on post-diagnostic measures, studies with prediagnostic selenium are needed for corroboration.

Keywords

References

  1. Aaseth J, Frey H, Glattre E, et al (1990). Selenium concentrations in the human thyroid gland. Biol Trace Elem Res, 24, 147-52. https://doi.org/10.1007/BF02917202
  2. Adjadj E, Schlumberger M, de Vathaire F (2009). Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol, 10, 181-90. https://doi.org/10.1016/S1470-2045(09)70020-8
  3. Arnaud J, Bertrais S, Roussel AM, et al (2006). Serum selenium determinants in French adults: the SU.VI.M.AX study. Brit J Nutr, 95, 313-20. https://doi.org/10.1079/BJN20051528
  4. Bleys J, Navas-Acien A, Laclaustra M, et al (2009). Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey, 2003-2004. Am J Epidemiol, 169, 996-1003. https://doi.org/10.1093/aje/kwn414
  5. Brauer VF, Schweizer U, Kohrle J, Paschke R (2006). Selenium and goiter prevalence in borderline iodine sufficiency. Eur J Endocrinol, 155, 807-12. https://doi.org/10.1530/eje.1.02302
  6. Brindel P, Doyon F, De Vathaire F, et al (2008). Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol, 28, 219-29.
  7. Brindel P, Doyon F, De Vathaire F, et al (2009). Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control, 20, 581-90. https://doi.org/10.1007/s10552-008-9266-y
  8. Brindel P, Doyon F, De Vathaire F, et al (2010). Family history of thyroid cancer and the risk of thyroid cancer in French Polynesia. Thyroid, 20, 393-400. https://doi.org/10.1089/thy.2009.0350
  9. Cann SA, van Netten JP, van Netten C (2000). Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control, 11, 121-7. https://doi.org/10.1023/A:1008925301459
  10. Clark LC, Combs GF, Turnbull BW, et al (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer study group. JAMA, 276, 1957-63. https://doi.org/10.1001/jama.1996.03540240035027
  11. Clero E, Doyon F, De Vathaire F, et al (2012). Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study. Thyroid, 22, 422-9. https://doi.org/10.1089/thy.2011.0173
  12. Clero E, Leux C, De Vathaire F, et al (2010). Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid, 20, 1285-93. https://doi.org/10.1089/thy.2009.0456
  13. De Vathaire F, Drozdovitch V, Brindel P, et al (2010). Thyroid cancer following nuclear tests in French Polynesia. Brit J Cancer, 103, 1115-21. https://doi.org/10.1038/sj.bjc.6605862
  14. Dewailly E, Chateau-Degat L, Suhas E (2008). Fish consumption and health in French Polynesia. Asia Pac J Clin Nutr, 17, 86-93.
  15. Dewailly E, Suhas E, Mou Y, et al (2008). High fish consumption in French Polynesia and prenatal exposure to metals and nutrients. Asia Pac J Clin Nutr, 17, 461-70.
  16. Dignan C, Burlingame B, Kumar S, Aalbersberg W (2004). The Pacific Islands food composition tables - second edition. Rome: FAO.
  17. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al (2002). Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev, 11, 630-9.
  18. Elwaer N, Hintelmann H (2007). Comparative performance study of different sample introduction techniques for rapid and precise selenium isotope ratio determination using multi-collector inductively coupled plasma mass spectrometry (MC-ICP/MS). Anal Bioanal Chem, 389, 1889-99. https://doi.org/10.1007/s00216-007-1537-z
  19. Fairweather-Tait SJ, Bao Y, Broadley MR, et al (2011). Selenium in human health and disease. Antioxid Redox Signal, 14, 1337-83. https://doi.org/10.1089/ars.2010.3275
  20. Favier JC, Ireland-Ripert J, Toque C, Feinberg M (1995). Repertoire general des aliments. Table de composition [Food composition tables] CIQUAL-REGAL. Paris: Tec & Doc Lavoisier and INRA.
  21. Fleckman P (1985). Anatomy and physiology of the nail. Dermatol Clin, 3, 373-81.
  22. Garland M, Morris JS, Rosner BA, et al (1993). Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev, 2, 493-7.
  23. Glattre E, Thomassen Y, Thoresen SO, et al (1989). Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol, 18, 45-9. https://doi.org/10.1093/ije/18.1.45
  24. Gudmundsson J, Sulem P, Gudbjartsson D, et al (2009). Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet, 41, 460-4. https://doi.org/10.1038/ng.339
  25. Guo KF, Zhang Z, Wang JY, et al (2012). Variation of urinary and serum trace elements (Ca, Zn, Cu, Se) in bladder carcinoma in China. Asian Pac J Cancer Prev, 13, 2057-61. https://doi.org/10.7314/APJCP.2012.13.5.2057
  26. Hunter DJ, Morris JS, Willett WC, et al (1990). Predictors of selenium concentration in human toenails. Am J Epidemiol, 132, 114-22. https://doi.org/10.1093/oxfordjournals.aje.a115623
  27. Jung HJ, Seo YR (2010). Current issues of selenium in cancer chemoprevention. Biofactors, 36, 153-8.
  28. Karimi G, Shahar S, Homayouni N, et al (2012). Association between trace element and heavy metal levels in hair and nail with prostate cancer. Asian Pac J Cancer Prev, 13, 4249-53. https://doi.org/10.7314/APJCP.2012.13.9.4249
  29. Kato MA, Finley DJ, Lubitz CC, et al (2010). Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34. Nutr Cancer, 62, 66-73.
  30. Kohrle J, Gartner R (2009). Selenium and thyroid. Best Pract Res Clin Endocrinol Metab, 23, 815-27. https://doi.org/10.1016/j.beem.2009.08.002
  31. Lloyd B, Lloyd RS, Clayton BE (1983). Effect of smoking, alcohol and other factors on the selenium status of a healthy population. J Epidemiol Community Health, 37, 213-17. https://doi.org/10.1136/jech.37.3.213
  32. Meinhold CL, Ron E, Schonfeld SJ, et al (2010). Nonradiation risk factors for thyroid cancer in the US radiologic technologists study. Am J Epidemiol, 171, 242-52. https://doi.org/10.1093/aje/kwp354
  33. Meplan C, Crosley LK, Nicol F, et al (2007). Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J, 21, 3063-74. https://doi.org/10.1096/fj.07-8166com
  34. Moncayo R, Kroiss A, Oberwinkler M, et al (2008). The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma. BMC Endocr Disord, 8, 2. https://doi.org/10.1186/1472-6823-8-2
  35. Moore MA, Baumann F, Foliaki S, et al (2010). Cancer epidemiology in the Pacific Islands - past, present and future. Asian Pac J Cancer Prev, 11, 99-106.
  36. Ortega RM, Rodriguez-Rodriguez E, Aparicio A, et al (2012). Young children with excess of weight show an impaired selenium status. Int J Vitam Nutr Res, 82, 121-9. https://doi.org/10.1024/0300-9831/a000101
  37. Ron E, Schneider AB (2006). Thyroid cancer. In: Schottenfeld D, Fraumeni J, editors. Cancer Epidemiology and Prevention. Oxford University Press, New York: pp. 975-94.
  38. Satia JA, King IB, Morris JS, Stratton K, White E (2006). Toenail and plasma levels as biomarkers of selenium exposure. Ann Epidemiol, 16, 53-8. https://doi.org/10.1016/j.annepidem.2005.02.011
  39. Singh P, Kapil U, Shukla NK, Deo S, Dwivedi SN (2005). Association between breast cancer and vitamin C, vitamin E and selenium levels: results of a case-control study in India. Asian Pac J Cancer Prev, 6, 177-80.
  40. Willett WC, Polk BF, Morris JS, et al (1983). Prediagnostic serum selenium and risk of cancer. Lancet, 2, 130-4.
  41. World Health Organization (2003). Diet, food supply and obesity in the Pacific. Geneva: regional office for the Western Pacific.
  42. Xhaard C, Ren Y, Clero E, et al (2014). Differentiated thyroid carcinoma risk factors in French Polynesia. Asian Pac J Cancer Prev, 15, 2675-80. https://doi.org/10.7314/APJCP.2014.15.6.2675

Cited by

  1. Selenium and the thyroid vol.22, pp.5, 2015, https://doi.org/10.1097/MED.0000000000000190